Search results for "Vaccines"
Modeling study finds RSV vaccines cost-effective for older U.S. adults
Vaccination programs using the monovalent adjuvanted or bivalent vaccine against respiratory syncytial virus (RSV) were projected to be potentially cost-effective at a price per dose of up to $127 or up to $118, respectively, over a first RSV season.
https://immattersacp.org/weekly/archives/2023/12/05/4.htm
5 Dec 2023
ACP urges adults to get their influenza vaccine during National Influenza Vaccination Week
ACP is urging all adults to get vaccinated as influenza season, holiday gatherings, and winter weather are here, along with the continued presence of COVID-19 and respiratory syncytial virus.
https://immattersacp.org/weekly/archives/2023/12/05/5.htm
5 Dec 2023
More clarity on myocarditis with mRNA COVID-19 vaccines
The classic presentation for COVID-19 vaccine-associated myocarditis is chest pain one to seven days after vaccination, with a median time of three days after vaccination, particularly after the second dose.
https://immattersacp.org/archives/2023/02/more-clarity-on-myocarditis-with-mrna-covid-19-vaccines.htm
1 Feb 2023
Fighting COVID-19 vaccine fallacies with facts
This issue addressed COVID-19 vaccination and integrating oral health into primary care.
https://immattersacp.org/archives/2021/11/fighting-covid-19-vaccine-fallacies-with-facts.htm
1 Nov 2021
CDC publishes recommendations on use of RSV vaccines
The two vaccines for respiratory syncytial virus (RSV) were approved by the FDA for older adults in May.
https://immattersacp.org/weekly/archives/2023/08/01/4.htm
1 Aug 2023
Keep up with vaccine recommendations
New vaccines and their recommendations have added complexity and made it tough to stay current. For patients, the extra costs can be prohibitive. Learn how to stay abreast of the requirements and engage patients on the issue.
https://immattersacp.org/archives/2013/09/vaccines.htm
1 Sep 2013
New COVID-19 vaccines tested, authorization changes in progress for existing vaccines
The FDA further limited use of the Johnson & Johnson (Janssen) vaccine and scheduled advisory committee meetings on other vaccine questions. Two non-mRNA vaccines showed effectiveness, and other studies looked at antibody prevalence, home test accuracy, and long-term symptoms.
https://immattersacp.org/weekly/archives/2022/05/10/2.htm
10 May 2022
Coadministration of zoster vaccine, COVID-19 booster appears safe, effective
An industry trial found that coadministration of an mRNA COVID-19 booster vaccine with a first dose of recombinant zoster vaccine was immunologically noninferior to spacing the shots two weeks apart, with a similar safety and reactogenicity profile.
https://immattersacp.org/weekly/archives/2023/06/27/2.htm
27 Jun 2023
Civil surgeons can help pave the way to citizenship
An FACP explains what a civil surgeon does and why he thinks more internal medicine physicians should consider doing it.
https://immattersacp.org/archives/2024/04/civil-surgeons-can-help-pave-the-way-to-citizenship.htm
1 Apr 2024
COVID-19 Vaccine Forum II—Promoting COVID-19 Vaccination: What Physicians Need to Know
The virtual live event hosted by ACP and Annals of Internal Medicine on Dec. 16 will provide unique insight and practical information from a panel of experts on promoting COVID-19 vaccination confidence and uptake.
https://immattersacp.org/weekly/archives/2020/12/08/2.htm
8 Dec 2020